Bank of New York Mellon Corp - SANA BIOTECHNOLOGY INC ownership

SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 92 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.02 and the average weighting 0.4%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of SANA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$1,431,424
-34.9%
369,877
+0.2%
0.00%
Q2 2023$2,200,044
+87.3%
369,135
+2.8%
0.00%
Q1 2023$1,174,764
-18.3%
359,255
-1.3%
0.00%
Q4 2022$1,438,420
-35.5%
364,157
-2.0%
0.00%
-100.0%
Q3 2022$2,230,000
+12.1%
371,664
+20.1%
0.00%
Q2 2022$1,990,000
-32.2%
309,482
-12.9%
0.00%
-100.0%
Q1 2022$2,936,000
-46.9%
355,442
-0.4%
0.00%0.0%
Q4 2021$5,524,000
-23.9%
356,811
+10.7%
0.00%0.0%
Q3 2021$7,258,000
+323.0%
322,278
+269.2%
0.00%
Q2 2021$1,716,000
+4.4%
87,301
+77.8%
0.00%
Q1 2021$1,644,00049,1050.00%
Other shareholders
SANA BIOTECHNOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 34,239,018$220,158,0008.29%
Crestline Management, LP 3,365,624$21,641,0002.82%
Omega Fund Management, LLC 843,750$5,425,0001.73%
Alphabet Inc. 2,812,500$18,084,0000.98%
HARVARD MANAGEMENT CO INC 468,749$3,014,0000.35%
PUBLIC SECTOR PENSION INVESTMENT BOARD 6,400,000$41,152,0000.35%
PFM Health Sciences, LP 952,733$6,126,0000.23%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 156,254$1,005,0000.20%
Viewpoint Capital Management LLC 23,545$151,0000.14%
Artal Group S.A. 400,000$2,572,0000.14%
View complete list of SANA BIOTECHNOLOGY INC shareholders